|
|
MODULE 6: Opioid Prescribing Update
Part of the 8-Hour DEA Training Bundle: Clinical Approaches to Pain Management and Substance Use Disorders
|
|
Facebook
LinkedIn
E-Mail
|
(198)
|
Activity Duration| Content Expires: | May 31, 2027 (11:55 p.m. CT)
CE for this activity will not be available after this date. |
 | This activity includes closed captioning. |
Overview
This module synthesizes major changes in opioid prescribing guidelines, including 2016 and 2022 CDC recommendations, updated 2025 prescribing trends, PDMP use, and risk mitigation practices. It reviews opioid selection, dosing, tapering principles, safety considerations (e.g., OIRD, benzodiazepine co-prescribing risk), documentation requirements, and patient-provider agreements. Learners gain practical guidance on safe, patient-centered opioid stewardship.
Objectives - Determine the appropriate circumstances for prescribing opioids by applying clinical guidelines and patient assessments.
- Discuss monitoring parameters necessary for prescribing chronic opioid therapy, including patient evaluation and risk management strategies.
- Identify two patient behaviors/situations that would warrant consideration for opioid weaning.
Speaker
Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, FAANP
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.The speaker has the following disclosures:
- Speakers’ Bureau:
- Pfizer & AbbVie (Migraine)
- Averitas Pharmaceuticals (PHN, DPN)
All Planners involved in this activity have no relevant financial relationships to disclose. All relevant financial relationships have been mitigated.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Submit the post-test. (No passing score required.)
- Submit the activity evaluation.
- Click on the Get Certificate button.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate and a record of your CE/Rx earned will be automatically added to your AANP CE Tracker.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1.28 Contact Hour(s) of CE,
All of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand)
MODULE 3: Non-Opioid Pharmacology Treatment of Pain
(OnDemand)
MODULE 5: Substance Use Disorders - Opioids
(OnDemand)
MODULE 1: Pathophysiology of Pain and Neurobiology of Addiction Overview
(OnDemand)
MODULE 7: Buprenorphine and Methadone
(OnDemand)
MODULE 2: Non-Pharmacologic Treatment of Pain
(OnDemand)
MODULE 4: Care Transitions and New Frontiers in SUD Treatment
(OnDemand)
MODULE 8: Special Populations and Opioid Use Disorder Treatment
(OnDemand)
Headaches: Everything but Migraine
(OnDemand)
The NP's Role in Substance Use Disorder Management: Screening, Diagnosis, and Treatment
(OnDemand)
A Focus on Men’s Health: Erectile Dysfunction and Testosterone Deficiency
(OnDemand)
Cognitive Decline and Diabetes in Older Adults
(OnDemand)
Hormones for Vasomotor Symptoms of Menopause: A Primer for the Primary Care Providers
|
|
Adding Registration, Please wait...
